Jump to Main Content
- Belle, Fabiën; Wengenroth, Laura; Weiss, Annette; Sommer, Grit; Beck Popovic, Maja; Ansari, Marc; Bochud, Murielle; Kuehni, Claudia
- Clinical nutrition 2017 v.36 pp. 1266-1274
- anthracyclines, etc ; adults; alcohol drinking; cardiovascular diseases; chest; childhood; chronic diseases; dairy products; dietary recommendations; education; fish; food intake; gender; health surveys; healthy diet; irradiation; meat; neoplasms; questionnaires; regression analysis; risk; risk groups; risk profile; siblings; sports; vegetables; Switzerland; Show all 27 Subjects
- ... Poor diet may increase the risk that childhood cancer survivors (CCS) will suffer from chronic disease. We compared adherence to national dietary recommendations between CCS, their siblings and the Swiss population, identified determinants of adherence, and assessed the association of adherence with cardiovascular disease (CVD) risk profiles.As part of the Swiss Childhood Cancer Survivor Study (SC ...
- Agarwal, Shweta; Jangir, Deepak Kumar; Mehrotra, Ranjana
- Journal of photochemistry and photobiology 2013 v.120 pp. 177-182
- anthracyclines, etc ; B-DNA; Fourier transform infrared spectroscopy; absorption; antineoplastic agents; drug therapy; pH; photobiology; photochemistry; risk; spectral analysis; Show all 11 Subjects
- ... Mitoxantrone (MTX) (1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione) is a synthetic antineoplastic drug, widely used as a potent chemotherapeutic agent in the treatment of various types of cancer. It is structurally similar to classical anthracyclines. Widespread interest in the anticancer agent mitoxantrone has arisen because of its apparent lower risk of cardio- ...
- Spector, Neil L.; Yarden, Yosef; Smith, Bradley; Lyass, Ljuba; Trusk, Patricia; Pry, Karen; Hill, Jason E.; Xia, Wenle; Seger, Rony; Bacus, Sarah S.
- Proceedings of the National Academy of Sciences of the United States of America 2007 v.104 no.25 pp. 10607-10612
- anthracyclines, etc ; AMP-activated protein kinase; apoptosis; beta oxidation; calcium; cardiomyocytes; cardiomyopathy; chelation; cytokines; drug therapy; epidermal growth factor receptors; humans; ischemia; monoclonal antibodies; patients; risk; rodents; stress response; California; Show all 19 Subjects
- ... The human EGF receptor (HER) 2 receptor tyrosine kinase is a survival factor for human cardiomyocytes, and its inhibition may explain the increased incidence of cardiomyopathy associated with the anti-HER2 monoclonal antibody trastuzumab (Genentech, South San Francisco, CA), particularly in patients with prior exposure to cardiotoxic chemotherapies e.g., anthracyclines. Here, we show that GW2974 ( ...
- PubMed Central: